U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: The FDA has, jointly with the Federal Trade Commission (FTC), issued a warning letter to Lattice Biologics, Ltd., for marketing an unapproved amniotic fluid product, sometimes referred to as AmnioBoost, to mitigate, prevent, treat, diagnose or cure Severe […]